|
|
Blood, 1 July 2005, Vol. 106, No. 1, pp. 141-143.
Prepublished online as a Blood First Edition Paper on March 17, 2005; DOI 10.1182/blood-2004-11-4188.
Previous Article | Next Article 
Submitted November 16, 2004
Accepted March 5, 2005
Cleavage of ultra-large multimers of Von Willebrand factor by C-terminal truncated mutants of ADAMTS-13 under flow
Zhenyin Tao, Yongtao Wang, Huiwei Choi, Aubrey Bernardo, Kenji Nishio, J E Sadler, Jose A Lopez, and Jing-fei Dong*
Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Hematology Division, Department of Medicine, Washington University, St. Louis, MO, USA
* Corresponding author; email: jfdong{at}bcm.tmc.edu.
ADAMTS-13 cleaves the A2 domain of von Willebrand factor, converting the ultra-large (UL) and hyperactive VWF multimers freshly released from endothelial cells to smaller and less active forms found in plasma. Recombinant ADAMTS-13 lacking the C-terminal region is active under static conditions, but its functions under flow conditions have not been determined. Here, we show that VWF-cleaving activity measured under flow was preserved in an ADAMTS-13 mutant lacking the 2nd to 8th TSP-1 motifs and the CUB domains, but was severely deficient in a mutant that was further truncated to remove the spacer domain. We also show that the mutant lacking the TSP-1 and CUB domains was hyperactive under flow, suggesting that the C-terminal region may negatively regulate ADAMTS-13 activity. The wild-type and the mutant without the spacer were more active in the presence of plasma, raising the possibility of ADAMTS-13 cofactors in plasma.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. de Groot, A. Bardhan, N. Ramroop, D. A. Lane, and J. T. B. Crawley
Essential role of the disintegrin-like domain in ADAMTS13 function
Blood,
May 28, 2009;
113(22):
5609 - 5616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Banno, A. K. Chauhan, K. Kokame, J. Yang, S. Miyata, D. D. Wagner, and T. Miyata
The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation
Blood,
May 21, 2009;
113(21):
5323 - 5329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Buzza, J. M. Dyson, H. Choi, E. E. Gardiner, R. K. Andrews, D. Kaiserman, C. A. Mitchell, M. C. Berndt, J.-F. Dong, and P. I. Bird
Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor
J. Biol. Chem.,
August 15, 2008;
283(33):
22498 - 22504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang, W. Pan, A. H. Rux, B. S. Sachais, and X. L. Zheng
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow
Blood,
September 15, 2007;
110(6):
1887 - 1894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhou, E. E. Bouhassira, and H.-M. Tsai
An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers
Blood,
August 1, 2007;
110(3):
886 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gendron, M. Kashiwagi, N. H. Lim, J. J. Enghild, I. B. Thogersen, C. Hughes, B. Caterson, and H. Nagase
Proteolytic Activities of Human ADAMTS-5: COMPARATIVE STUDIES WITH ADAMTS-4
J. Biol. Chem.,
June 22, 2007;
282(25):
18294 - 18306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Shang, X. W. Zheng, M. Niiya, and X. L. Zheng
Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts
Blood,
October 1, 2006;
108(7):
2207 - 2215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Donadelli, J. N. Orje, C. Capoferri, G. Remuzzi, and Z. M. Ruggeri
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood
Blood,
March 1, 2006;
107(5):
1943 - 1950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Soejima, H. Nakamura, M. Hirashima, W. Morikawa, C. Nozaki, and T. Nakagaki
Analysis on the Molecular Species and Concentration of Circulating ADAMTS13 in Blood
J. Biochem.,
January 1, 2006;
139(1):
147 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Plaimauer, J. Fuhrmann, G. Mohr, W. Wernhart, K. Bruno, S. Ferrari, C. Konetschny, G. Antoine, M. Rieger, and F. Scheiflinger
Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
Blood,
January 1, 2006;
107(1):
118 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Tao, Y. Peng, L. Nolasco, S. Cal, C. Lopez-Otin, R. Li, J. L. Moake, J. A. Lopez, and J.-f. Dong
Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions
Blood,
December 15, 2005;
106(13):
4139 - 4145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ai, P. Smith, S. Wang, P. Zhang, and X. L. Zheng
The Proximal Carboxyl-terminal Domains of ADAMTS13 Determine Substrate Specificity and Are All Required for Cleavage of von Willebrand Factor
J. Biol. Chem.,
August 19, 2005;
280(33):
29428 - 29434.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|